Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | CCR6 | P51684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2262288 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL2261252 | 0.71 | — | — | |
| SCHEMBL616019 | 0.70 | — | — | |
| SCHEMBL10591353 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL28869240 | 0.67 | — | — | |
| SCHEMBL17118248 | 0.64 | — | — | |
| Pyrrole SCHEMBL16612135 | 0.61 | — | — | |
| SCHEMBL12338441 | 0.60 | GSK3A (0.30) | GSK3AGSK3BCCR6 | |
| Trimethylammonium SCHEMBL28631750 | 0.60 | — | — | |
| SCHEMBL28448992 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1344778-B1 | Bipyrrolinonylidene-type compound, its use as colorant, and method of production thereof | DAINIPPON INK & CHEMICALS (JP) | 2008-09-03 | — | — | EP | claimed |
| EP-1344778-B1 | Bipyrrolinonylidene-type compound, its use as colorant, and method of production thereof | DAINIPPON INK & CHEMICALS (JP) | 2008-09-03 | — | — | EP | disclosed |
| EP-1344778-B1 | Bipyrrolinonylidene-type compound, its use as colorant, and method of production thereof | DAINIPPON INK & CHEMICALS (JP) | 2008-09-03 | — | — | EP | disclosed |
| CN-100343231-C | Dipyrrolinone subunit compound, coloring agent containing said compound and its preparation method | DAINIPPON INK & CHEMICALS (JP) | 2007-10-17 | — | — | CN | disclosed |
| US-6740153-B2 | AIR OXIDIZING A PYRROLINONE IN THE PRESENCE OF AN ANTHRAQUINONE CATALYST | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2004-05-25 | — | — | US | disclosed |
| CN-1443757-A | Dipyrrolinone subunit compound, coloring agent containing said compound and its preparation method | DAINIPPON INK & CHEMICALS (JP) | 2003-09-24 | — | — | CN | disclosed |
| US-20030172478-A1 | Bipyrrolinonylidene-type compound, colorant therewith, and method of producton thereof | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-09-18 | — | — | US | disclosed |
| EP-1344778-A1 | Bipyrrolinonylidene-type compound, its use as colorant, and method of production thereof | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-09-17 | — | — | EP | disclosed |
| EP-1344778-A1 | Bipyrrolinonylidene-type compound, its use as colorant, and method of production thereof | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030172478-A1 | Bipyrrolinonylidene-type compound, colorant therewith, and method of producton thereof | PPOX, NDUFS6, POR | GSK3A 4412/4885GSK3B 4478/4885CCR6 3288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.